Cargando…
Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling
Autores principales: | Hobbs, R, Fu, D, Pomper, M, Ambinder, R, Sgouros, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261784/ http://dx.doi.org/10.1186/1750-9378-4-S2-P23 |
Ejemplares similares
-
Monte Carlo simulations in radiotherapy dosimetry
por: Andreo, Pedro
Publicado: (2018) -
A BETR way to track toxic pollutants.
por: Dahl, Richard
Publicado: (2002) -
Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir
por: Shirley, Courtney M, et al.
Publicado: (2012) -
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009) -
Monte Carlo applications to photon radiation protection and dosimetry at ENEA
por: Guaraldi, R, et al.
Publicado: (1993)